Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Cronos Group Inc.TSX: CRON.TO

Operating Margin · Q1 FY2026 · quarter ended Mar 2026

Operating margin widens to -3.2%

Operating margin was -3.2% in Q1 FY2026, up 7.7 pp from a year earlier. On a trailing-twelve-month basis it was -7.8%, up 43.6 pp year over year. Over 3 fiscal years it widened by 116.5 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 4 analysts of 35.4% for the fiscal year ending Dec 2026, up from -12.0% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-3.2%+8.1 pp QoQ
Last fiscal yearDec 2025
-12.0%+53.1 pp YoY
LTMMar 2026
-7.8%+43.6 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+7.7 pp+25.1 pp+17.4 pp
1 year+53.1 pp+47.4 pp-5.7 pp
3 years+116.5 pp+40.5 pp-76.0 pp
5 years+37.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-12.0%
Year-over-year change
+53.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • CRON.TO's LTM Mar 2026 operating margin of -7.8% is the 5th highest of the 6 companies compared; the peer median is 8.1%.
  • Its year-over-year change of +43.6 pp is the highest of 6, against a peer median of +1.1 pp.
  • Over three fiscal years its change of +116.5 pp compares with a peer median of +0.3 pp.
CRON.TO Competitors Peer median
Operating Margin for CRON.TO and competitors
Company Period LTM level YoY 3-year change
SIA.TOSienna Senior Living Inc.LTM Sep 202610.0% -3.6 pp-5.0 pp
EXE.TOExtendicare Inc.LTM Jun 20268.8% +1.1 pp+6.6 pp
WELL.TOWELL Health Technologies Corp.LTM Mar 20268.1% +11.3 pp+4.0 pp
GUD.TOKnight Therapeutics Inc.LTM Mar 20262.7% +2.9 pp+0.3 pp
CRON.TOCronos Group Inc.LTM Mar 2026-7.8% +43.6 pp+116.5 pp
TLRY.TOTilray Brands, Inc.LTM Feb 2026-174.2% -86.4 pp-262.2 pp
Peer median (excluding CRON.TO) 8.1%+1.1 pp+0.3 pp

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue64.02M87.54M87.03M117.5M149.15M
Cost of Revenue81.47M71.96M75.15M87.05M87.45M
Gross Profit(17.45M)15.58M11.88M30.45M61.7M
Gross Margin-27.3%17.8%13.7%25.9%41.4%
Research & Development21.66M13.25M5.83M4.22M4.53M
Selling, General & Admin120.67M101.64M80.74M76.74M75.01M
Operating Expenses272.09M128.01M96.48M106.91M79.54M
Depreciation & Amortization13.36M11.52M7.44M8.84M14.48M
EBITDA(150.79M)(93.81M)(72.28M)(45.37M)(2.94M)
EBITDA Margin-235.5%-107.2%-83.0%-38.6%-2.0%
Operating Income(289.54M)(112.44M)(84.6M)(76.46M)(17.84M)
Operating Margin-452.2%-128.4%-97.2%-65.1%-12.0%
Interest Income8.92M21.84M52.07M49.52M40.66M
Interest Expense00000
Other Income / Expenses162.1M(9.66M)11.1M113.01M419.21K
Income Before Tax(127.44M)(122.1M)(73.49M)36.55M(17.42M)
Pre-Tax Margin-199.1%-139.5%-84.4%31.1%-11.7%
Income Tax Expense(427.41K)34.48M(3.23M)(3.44M)(14.44M)
Net Income(392.81M)(170.26M)(73.79M)41.04M(9.61M)
Net Margin-613.5%-194.5%-84.8%34.9%-6.4%
EPS (Basic)(0.34)(0.42)(0.18)0.10(0.03)
EPS (Diluted)(0.34)(0.42)(0.18)0.10(0.03)
Weighted Avg Shares369.73M370.39M380.96M382.16M383.47M
Weighted Avg Shares (Diluted)370.39M370.39M380.96M382.16M383.47M

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.